 |
11th Winter Conference on Medicinal & Bioorganic Chemistry
January 20, 2013–January 24, 2013
Steamboat Springs, Colorado
Quality by Design
January 23, 2013–January 24, 2013
London, United Kingdom Social Media in the Pharmaceutical Industry
January 23, 2013–January 24, 2013
London, United Kingdom Pre-Filled Syringes
January 28, 2013–January 29, 2013
London, United Kingdom CBI's 4th Annual Effective Preparation for FDA Advisory Committee Meetings
February 5, 2013–February 6, 2013
Washington, DC
|
|
|
 |
 
 |
 Peristaltic pumps offer contamination-free pumping capabil
Watson-Marlow’s new Bp pump features Profibus networking to the well-known benefits of peristaltic pumping, making it easy and efficient for customers to integrate this seal-less, valveless pump technology into their Profibus control system. Compared with non-networked pumps, the Bp range features Profibus compatible units that reduce engineering, hardware and installation costs, as well as offer remote diagnostics to help minimize plant downtime and maintenance costs.
|
|
|
 |
|
Biogen Idec has opened its new facility in Research Triangle Park (RTP), North Carolina, consolidating its 300-person patient-services operation with the existing RTP campus. The new 190,000-ft2 building is anticipated to achieve LEED-Gold certified status in the next several months and will accommodate increasing levels of manufacturing activity at the site. The official groundbreaking for the building took place in April 2011. Read More
IMPORTFAB is a well-established contract manufacturer, specializing in the manufacturing and packaging of semi-solid and
liquid products. Our objective is to maintain our position as a reliable reference point in the manufacturing of quality pharmaceutical products: essentially, a benchmark for modern, efficient production, assured through the use of highly performing equipment. IMPORTFAB is cGMP compliant by the FDA and Health Canada.  www.importfab.com
|
Tekmira Pharmaceuticals, a developer of RNA interference (RNAi) therapeutics, has obtained a worldwide, nonexclusive license to an RNAi payload technology called Unlocked Nucleobase Analog (UNA) from Marina Biotech for the development of RNAi therapeutics. UNA technology can be used in the development of RNAi therapeutics, which treat disease by silencing specific disease-causing genes. UNAs can be incorporated into RNAi drugs and have the potential to improve them by increasing their stability and reducing off-target effects. Read More
At Solvay Chemicals, we manufacture BICAR® Sodium Bicarbonate and Soda Ash IPH to meet the exacting specifications of the US and EP Pharmacopeias and National Formulary. Produced according to cGMP, these are the products of choice for API or excipient applications requiring effervescent or desiccant properties. Solvay Chemicals, Inc. is part of the Solvay Group, the leading global producer of sodium bicarbonate and soda ash  http://www.solvaychemicals.us/EN/markets/Markets.aspx |
TOT Biopharm has completed an 18-month construction project in the first stage of its $100-million factory complex in eastern China’s Suzhou Industrial Park. The factory complex specializes in the R&D, production, and marketing of anticancer drugs globally. The first stage of TOT Biopharm’s new factory complex includes an oral anticancer drug plant with separate production facilities for both cytotoxics and noncytotoxics, an injected anticancer drug plant, and a GMP bio pilot plant with a capacity of 500 L for cell culture, purification, and filling. Read More
Accelerate the Development of Challenging Drug Candidates via Crystal Engineering
Live Webcast: Thursday, December 6, 2012 from 10:00 AM -11:15 AM EST
Register Free at  www.pharmtech.com/engineering |
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to [email protected] |
|
|
|
 |
| Examining the Growing Challenge of Extractables and Leachables |
by: Stephanie Sutton
Experts share insight into extractables and leachables testing, including high-risk products, analytical testing, and regulatory requirements from FDA and EMA.
 |
Coming soon: Pharm Tech’s January issue features a look ahead in manufacturing. |
|
|
Participate in the bio-industry's most in-depth, global study: 10th Annual Biopharmaceutical Manufacturing Report and Survey.
Your input is more important than ever, as we benchmark global and regional trends affecting our industry. You will receive a summary of the results of this important global study. AND for each completed survey we’ll donate a select amount to global health charities. Takes between 10–25 minutes, depending on your areas of expertise.
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounds, new product releases, booth materials, and more.
PharmTech's online
Gateway is your guide to the season's leading shows.
|
|
|
|
|
|
